Key Points
- CEO Parth Mehrotra sold a total of 165,037 shares in multiple March transactions (largest single-day sale 41,999 on Mar 9), generating roughly $3.69 million and reducing his holdings to 555,443 shares (a ~4.56% decrease).
- Privia reported a quarterly earnings beat (EPS $0.25 vs. $0.04) with 17.4% YoY revenue growth, and Wall Street is generally positive—13 Buy and 3 Hold ratings with a consensus target of $31.00—while the stock trades in the low-$20s (50-day $22.75, 200-day $23.60).
Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) CFO David Mountcastle sold 6,391 shares of the stock in a transaction on Monday, March 16th. The shares were sold at an average price of $22.11, for a total transaction of $141,305.01. Following the transaction, the chief financial officer directly owned 220,413 shares in the company, valued at approximately $4,873,331.43. The trade was a 2.82% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
David Mountcastle also recently made the following trade(s):
- On Friday, March 13th, David Mountcastle sold 6,565 shares of Privia Health Group stock. The stock was sold at an average price of $21.52, for a total transaction of $141,278.80.
- On Thursday, March 12th, David Mountcastle sold 6,453 shares of Privia Health Group stock. The stock was sold at an average price of $21.90, for a total transaction of $141,320.70.
- On Monday, March 9th, David Mountcastle sold 5,829 shares of Privia Health Group stock. The shares were sold at an average price of $22.84, for a total transaction of $133,134.36.
- On Friday, March 6th, David Mountcastle sold 5,177 shares of Privia Health Group stock. The stock was sold at an average price of $23.15, for a total value of $119,847.55.
- On Thursday, February 26th, David Mountcastle sold 5,361 shares of Privia Health Group stock. The stock was sold at an average price of $25.00, for a total value of $134,025.00.
- On Friday, February 27th, David Mountcastle sold 7,697 shares of Privia Health Group stock. The shares were sold at an average price of $25.05, for a total value of $192,809.85.
Privia Health Group Stock Up 1.2%
Shares of NASDAQ PRVA traded up $0.27 during midday trading on Thursday, hitting $21.86. The stock had a trading volume of 26,945 shares, compared to its average volume of 797,856. The company has a market capitalization of $2.70 billion, a PE ratio of 128.47, a P/E/G ratio of 1.39 and a beta of 0.82. The stock has a 50 day simple moving average of $22.75 and a 200-day simple moving average of $23.60. Privia Health Group, Inc. has a 1 year low of $18.77 and a 1 year high of $26.51.
Privia Health Group (NASDAQ:PRVA - Get Free Report) last issued its quarterly earnings results on Thursday, February 26th. The company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.04 by $0.21. Privia Health Group had a return on equity of 3.06% and a net margin of 1.08%.The firm had revenue of $541.17 million during the quarter, compared to analysts' expectations of $516.61 million. During the same period in the previous year, the business earned $0.21 earnings per share. The firm's revenue for the quarter was up 17.4% on a year-over-year basis. As a group, analysts expect that Privia Health Group, Inc. will post 0.14 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of equities research analysts have recently commented on PRVA shares. Weiss Ratings reiterated a "hold (c)" rating on shares of Privia Health Group in a research report on Monday, December 29th. Canaccord Genuity Group boosted their price target on shares of Privia Health Group from $34.00 to $35.00 and gave the stock a "buy" rating in a research report on Friday, February 27th. Piper Sandler reaffirmed an "overweight" rating and set a $36.00 price objective on shares of Privia Health Group in a research note on Thursday, February 26th. Royal Bank Of Canada started coverage on shares of Privia Health Group in a report on Friday, January 9th. They issued an "outperform" rating and a $31.00 price objective for the company. Finally, Citigroup decreased their target price on shares of Privia Health Group from $34.00 to $32.00 and set a "buy" rating on the stock in a research note on Tuesday, March 3rd. Thirteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $31.00.
Read Our Latest Research Report on PRVA
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of PRVA. Van Berkom & Associates Inc. boosted its position in shares of Privia Health Group by 30.1% during the 3rd quarter. Van Berkom & Associates Inc. now owns 3,774,565 shares of the company's stock valued at $93,987,000 after acquiring an additional 873,344 shares during the last quarter. Vanguard Group Inc. increased its position in Privia Health Group by 5.3% during the third quarter. Vanguard Group Inc. now owns 12,098,933 shares of the company's stock worth $301,263,000 after purchasing an additional 607,447 shares during the last quarter. ArrowMark Colorado Holdings LLC raised its stake in Privia Health Group by 139.4% during the fourth quarter. ArrowMark Colorado Holdings LLC now owns 841,266 shares of the company's stock worth $19,946,000 after purchasing an additional 489,866 shares during the period. Algert Global LLC raised its stake in Privia Health Group by 277.4% during the third quarter. Algert Global LLC now owns 484,304 shares of the company's stock worth $12,059,000 after purchasing an additional 355,966 shares during the period. Finally, Freestone Grove Partners LP boosted its holdings in Privia Health Group by 40.6% in the 4th quarter. Freestone Grove Partners LP now owns 1,213,342 shares of the company's stock valued at $28,768,000 after purchasing an additional 350,194 shares during the last quarter. Hedge funds and other institutional investors own 94.48% of the company's stock.
Privia Health Group Company Profile
(
Get Free Report)
Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.
Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
